Close Menu
    Wall Street

    I see fat people everywhere – 100k on NVO


    Like title said, I keep seeing fat people everywhere I go. They are now valued at even cheaper than pre- ozempic price. And pill forms about to come out. WHO doesn’t want skinny pills. 2500 shares @ $39.73

    https://i.redd.it/y6dx0lnsfblg1.jpeg

    Posted by DingDongDingDong6969

    48 Comments

    3. Apprehensive_Bus_206 on

      You arent wrong. On the last part tho, I think you are forgetting that there’ll be a better “skinny pills” available. That’s actually the reason of the drop 😅 , they just lost their edge to Lily.

    4. dragoon7201 on

      problem is they are losing market share while ozempic is hot. And they will be losing their patent for Semaglutide (Ozempic) in a bunch of countries 2026-2027.

      And they don’t have much else in the pipeline… So ya, explains the stock price really

    5. dark199991 on

      Who need skinny pills when we will get skinny naturally because we don’t eat as much since it is more expensive.

    6. LonelyTAA on

      You haven’t been paying attention to the GLP1 market lol. Ozempic is old news, only half as effective as newer drugs like Mounjaro. Hell, I’m pretty badly informed so Mounjaro js likely old news by now

    8. commandedbydemons on

      Ozempic is trash.

      Elli Lilly is the GOAT.

      Tirzepatide, and end of the year with Retatrutide murdering the clinical trials

    9. BillysCoinShop on

      Its more a call if the insurance companies are going to cover said fat people, and on whose dime.

    10. Savings_Refuse_5922 on

      Probably not the play with Lily owning Reta their triple action GLP=1 which will come to market soon enough. Reta will be the new thing and you already have everyone from wine moms to bodybuilders and normal people sourcing it grey market right now because it’s so good before it even gets officially to market.

      tldr; Would rather gamble on Lily long term going up with Reta in the pipeline as well as comparable if not better products than Novo.

    11. Spy008 on

      All they did was release the pill version of ozempic….boring.

      Robs people the joys of shooting up IMO. Eli Lilly all the way

    12. EnvironmentalPear695 on

      Even the startups have better portfolios than NVO, and that’s not even putting LLY which is the market leader into consideration

    13. Withoutanymilk77 on

      NVO develops ozempic – stock skyrockets
      LLY – develops an ozempic clone – stock skyrockets

      LLY has a slightly better test result with their medication – NVO stock crashes

      Everyone – whelp that’s it, it’s over, NVO is done. No way they could develop a better medication. They’re only a $134 billion dollar corporation. One and done. Whole company better just give up. They definitely arnt even trying to develop anything new.

    15. T0th3M00NW3G0 on

      I wish I hadn’t started buying this in the low 60’s otherwise i prob would’ve done the exact same thing here. I added today but I wish I was starting a position today

    20. ChampagneWastedPanda on

      Last night I learned from 2025 CDC statistics that the average American woman over 20 is 5’3” and 170lbs. Like holy fat fucks America

    22. AwkwardObjective5360 on

      I’m fat and you’re an idiot.

      Tirzepatide is just as effective and less side effects.

      Also Lilly is better than Novo at formulary placement.

    23. lithe_silhouette on

      Smart money exits a stock after rigorous analysis, price drops, wsb regard sees big drop, thinks big opportunity, let me go all in before anyone else notices it

    24. DantefromMalta27 on

      Lilly has a superior product and Americans know how to run companies and make money, Novo dropped the bag and its over ( speaking as a NVO stock holder)

    26. 19kjc87 on

      Nice. How many of those fat ppl can afford it since most insurance companies don’t cover it for obesity?

    29. LiamPhlegmsworth on

      Semaglutide inferior to Tirzapetide and losing patents soon. NVO’s pipeline is booty hoe. VKTX has a p3 oral/SQ that will compete with Tirz for BIC weight loss and put NVO in the cuck chair as it’s firmly outclassed by both. Good luck with that!

    31. DiminishedProspects on

      Market isn’t paying for glp-1 exposure/shortage anymore, has shifted to paying for product efficacy/pipeline.

      Disclosure : long LLY. I’ve certainly been wrong before. Best of luck to you.

    32. Bruin1217 on

      Am I the only one who mistook Nordisk for Sandisk and wanted to know how fat people KPI’s affect data storage?

    33. IdkAbtAllThat on

      Counterpoint. If fat people were motivated enough to do something about it, they wouldn’t still be fat.

      (I still own a bunch of NVO)

    37. RamoneBolivarSanchez on

      **”Jarvis, we’re running out of time, quickly increase global PAWG supply by 10x”**

    38. politicalinvestor on

      People don’t realize how drugs work. People already seeing results that’ve been fat af for years you think they’re going to risk going back to doctor and trying to find another magic drug to get un fat faster or just keep having the doc send same script in that’s working fine. I don’t get on addy 30’s cracked outta my head and ask doc for more risking my whole bag to try and get meth.

    43. Minimum-Reward3264 on

      Lots of mind bending. But if you check bodybuilding and other looks related Reddit just about everyone is doing Reta.

    44. wumr125 on

      The competition has had better drugs for years

      Their patent expired in Canada due to sloppy paperwork and candian generics will be produced incessantly

      They coasted on being the first and now they are dead like your savings

    46. IHadTacosYesterday on

      Whenever something drops pretty dramatically, it seems like there’s lots of people that will rush in and play the contrarian, and come up with a thesis on how they turn it all around and they full port into it.

      I think this is a mistake more often than not.

      I did this with PayPal, Roku and Pintrest and in each case, I lost thousands upon thousands. Luckily with Roku, I saw my mistake really early on and took my loss. PayPal and Pintrest took me a long time to finally capitulate

    47. Odd-Elderberry-6137 on

      Too early. It’s gonna drop at least another 3-5%. It’s starting to get priced for failure. 

      Long term it’s a good play though.

    48. Big_Dick_John_Andy on

      brother, they dropped it and will continue to drop it knowing you will buy, they are going to take profit until it’s at 10 dollars and then rebuy at that price

    Leave A Reply
    Share via